Managing False-Positive Screening Results & Callbacks

Most people are told some version of "we saw something and we want another look." That sentence is doing a specific job. It means the screening test could not close the question — not that a cancer has been found. Fewer than 1 in 10 women recalled after a screening mammogram turn out to have breast cancer, and most biopsies that follow do not show cancer either.

Knowing the shape of the next few weeks makes them easier to sit through.

Mammogram reports use BI-RADS categories, and the category drives what happens next.

• BI-RADS 0 — incomplete. The most common callback. You return for a diagnostic mammogram (more views, different angles or compression) and often a targeted ultrasound of the same spot. Many centers read these while you wait.
• BI-RADS 3 — probably benign. The finding looks almost certainly harmless but has not been seen before. Instead of a biopsy, you have repeat imaging in about 6 months to confirm it is not changing.
• BI-RADS 4 or 5 — biopsy recommended. Usually a needle biopsy under image guidance, as an outpatient visit. Most biopsy results are not cancer, but a biopsy is the only way to be sure.

• Positive stool test (FIT, stool DNA) or blood-based colorectal test. The next step is a colonoscopy, and only a colonoscopy. It is both the diagnostic step and the step that removes polyps. The benefit of the original test is only realised if the colonoscopy actually happens.
• Positive HPV test. What follows depends on which HPV type was found, the cell (cytology) result, and your prior screening history. It may mean colposcopy, a repeat test in one year, or a return to routine screening. HPV types 16 and 18 usually prompt colposcopy.
• Lung nodule on a screening CT. Most nodules are not cancer. Reports use Lung-RADS categories; common next steps are a repeat CT at 3, 6 or 12 months, sometimes a PET scan, sometimes a biopsy.
• Elevated PSA. Usually a repeat test first, because PSA fluctuates, sometimes an MRI, and a biopsy only if the picture holds.

When the call comes, ask three things: what exactly are we looking at, what is the next test, and when. Then ask who calls you with the result and by what date. If that date passes, call.

Two practical things genuinely speed this up:

• Prior images. If earlier mammograms or scans were done elsewhere, have them sent. A finding that is stable on comparison often ends the question on the spot.
• Same-visit reading. Many breast centers read diagnostic images before you leave. Ask when you book, and ask for an appointment slot where that is possible.

Screening tests are generally covered without cost sharing under most US insurance. Follow-up tests are frequently billed as diagnostic, which can mean a deductible or a copay. Two exceptions are worth knowing:

• Under most private plans, a follow-up colonoscopy after a positive stool-based screening test must be covered without cost sharing.
• Medicare covers a follow-up colonoscopy after a positive stool or blood-based screening test, though coinsurance can still apply if a polyp is removed, and bowel prep, anesthesia and facility fees may be billed separately.

Ask the scheduler how the follow-up will be coded before the appointment, not after the bill arrives.

The gap between "we saw something" and "here is what it is" is the hardest stretch, and most of it is out of your hands. What is in your hands: know the date the result is due, bring someone to the appointment or to the phone call, and write your questions down in advance — it is genuinely hard to think clearly in that room.

If the finding turns out to be nothing, that is not a wasted trip. That is the system doing exactly what it was built to do.

• American Cancer Society — Getting Called Back After a Mammogram
• USPSTF — Colorectal Cancer: Screening
• ACOG — Updated Guidelines for Management of Cervical Cancer Screening Abnormalities
• American Cancer Society — Insurance Coverage for Colorectal Cancer Screening